Norman Broadbent plc (AIM:NBB)
London · Delayed Price · Currency is GBP · Price in GBX 250.00
+5.00 (2.04%)
Jan 22, 2026, 9:26 AM GMT
Norman Broadbent Revenue
In the year 2024, Norman Broadbent had annual revenue of 10.92M GBP, down -11.27%. Norman Broadbent had revenue of 5.88M in the half year ending December 31, 2024, with 23.44% growth.
Revenue
10.92M
Revenue Growth
-11.27%
P/S Ratio
0.41
Revenue / Employee
188.26K
Employees
58
Market Cap
4.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.92M | -1.39M | -11.27% |
| Dec 31, 2023 | 12.31M | 3.61M | 41.50% |
| Dec 31, 2022 | 8.70M | 2.15M | 32.80% |
| Dec 31, 2021 | 6.55M | -1.27M | -16.21% |
| Dec 31, 2020 | 7.82M | -3.67M | -31.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hays plc | 6.61B |
| PageGroup | 1.64B |
| SThree | 1.38B |
| Staffline Group | 1.03B |
| Robert Walters | 835.60M |
| Gattaca | 398.90M |
| Empresaria Group | 242.20M |
| RTC Group | 96.00M |
Norman Broadbent News
- 2 months ago - Half Year 2025 Norman Broadbent PLC Investor Presentation Transcript - GuruFocus
- 4 months ago - UK Stock Market News: Gaming Realms, Norman Broadbent, Foxtons - The Armchair Trader
- 7 months ago - AIM Market Roundup: Futura Medical, Norman Broadbent, Dekel Agri-Vision - The Armchair Trader
- 8 months ago - AIM Market Roundup: Ironveld, Norman Broadbent, TheWorks - The Armchair Trader
- 1 year ago - Three Quick Facts: Norman Broadbent, Computacenter, Immupharma - The Armchair Trader